Healthcare Sector
Market Tracker
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 08/21/2026 | CALL | $7.50 | 920 | +920 | |
| 01/15/2027 | CALL | $5.00 | 980 | +100 | +11.36% |
| 04/17/2026 | CALL | $3.00 | 587 | +46 | +8.50% |
| 11/20/2026 | CALL | $3.00 | 10 | +10 | |
| 04/17/2026 | CALL | $0.50 | 0 | 0 | |
| 04/17/2026 | CALL | $1.00 | 0 | 0 | |
| 01/15/2027 | CALL | $2.50 | 367 | -1 | -0.27% |
| 05/15/2026 | CALL | $2.50 | 15,020 | -3 | -0.02% |
| 05/15/2026 | CALL | $3.50 | 817 | -6 | -0.73% |
| 01/15/2027 | PUT | $2.50 | 16 | -10 | -38.46% |
| 04/17/2026 | CALL | $4.00 | 3,057 | -20 | -0.65% |
| 05/15/2026 | CALL | $5.00 | 3,489 | -100 | -2.79% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Alger Small Cap Focus Fund | 7.35% | 2.17M | 26.02M |
| Vanguard Total Stock Market Index Fund | 1.96% | 577.87k | 6.94M |
| Alger Fds II-Alger Dynamic Opportunities Fund | 1.47% | 434.01k | 5.21M |
| Vanguard Extended Market Index Fund | 0.95% | 280.64k | 3.37M |
| PGIM Jennison Health Sciences Fd | 0.87% | 257.29k | 3.09M |
| Fidelity Extended Market Index Fund | 0.40% | 117.05k | 1.41M |
| Bridgeway Funds Inc-Ultra Small Company Market Fund | 0.37% | 107.73k | 1.29M |
| Alger Fund-Small Cap Growth Fund | 0.34% | 100.54k | 1.21M |
| Dimensional ETF Tr-Dimensional U.S. Small Cap ETF | 0.23% | 67.11k | 805.99k |
| Bridgeway Funds Inc-Ultra Small Company Fund | 0.22% | 63.62k | 764.09k |
Cabaletta Bio Announces New Rese-cel Safety and Efficacy Data in Patients with Myositis, Lupus and Scleroderma to Be Presented at the EULAR 2025 Congress
06/11 06:00 am
GlobeNewswire Inc.
Read moreCabaletta Bio to Participate in the Jefferies Global Healthcare Conference
05/29 08:00 am
GlobeNewswire Inc.
Read moreCabaletta Bio to Participate in Guggenheim’s SMID Cap Biotech Conference
01/29 09:00 am
GlobeNewswire Inc.
Read moreUS Stocks Likely To Open In The Green To End November On A High: Are Markets Set For A Santa Claus Rally In December? Analysts Decode
11/29 07:46 am
Benzinga
Read moreCabaletta Bio to Participate in Upcoming Investor Conferences in September
08/28 08:00 am
GlobeNewswire Inc.
Read moreCabaletta Bio Reports Positive Initial Clinical Data from Phase 1/2 RESET-Myositis™ and RESET-SLE™ Trials of CABA-201
06/14 02:00 am
GlobeNewswire Inc.
Read moreCabaletta Bio Reports First Quarter 2024 Financial Results and Provides Business Update
05/15 07:00 am
GlobeNewswire Inc.
Read moreCabaletta Bio to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
05/13 08:00 am
GlobeNewswire Inc.
Read moreWall Street Breakfast: The Week Ahead
05/05 06:27 am
Seeking Alpha
Read moreCabaletta Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
03/21 07:00 am
GlobeNewswire Inc.
Read moreCramer: This REIT Is 'A Little Too Dicey'; As For Marathon Digital, 'Own The Pure'
03/06 10:20 am
Benzinga
Read moreCabaletta Bio Announces FDA Granted Orphan Drug Designation to CABA-201 for Treatment of Myositis
02/01 05:30 pm
GlobeNewswire Inc.
Read moreVerint Reports Strong Earnings, Joins Semtech, Alphabet And Other Big Stocks Moving Higher On Thursday
12/07 11:17 am
Benzinga
Read moreAnalyst Ratings for Cabaletta Bio
11/29 08:00 am
Benzinga
Read moreLeslie's Posts Weak Earnings, Joins Las Vegas Sands, Verve Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
11/29 06:48 am
Benzinga
Read moreCabaletta Bio’s and Gracell’s stock falls sharply as FDA investigates risks of CAR-T therapy
11/28 06:04 pm
MarketWatch
Read moreCabaletta Bio to Participate in the 6th Annual Evercore ISI HealthCONx Conference
11/28 05:30 pm
GlobeNewswire Inc.
Read moreCantor Fitzgerald Maintains Overweight Rating for Cabaletta Bio: Here's What You Need To Know
11/15 01:00 pm
Benzinga
Read moreWhere Cabaletta Bio Stands With Analysts
11/10 11:00 am
Benzinga
Read moreCabaletta Bio Reports Third Quarter 2023 Financial Results and Provides Business Update
11/09 08:00 am
GlobeNewswire Inc.
Read moreCabaletta Bio to Participate in Multiple Upcoming Investor Conferences in November
10/30 08:00 am
GlobeNewswire Inc.
Read moreBenzinga's Top Ratings Upgrades, Downgrades For October 24, 2023
10/24 11:00 am
Benzinga
Read more7 Analysts Have This to Say About Cabaletta Bio
10/24 08:00 am
Benzinga
Read moreBenzinga's Top Ratings Upgrades, Downgrades For October 19, 2023
10/19 11:06 am
Benzinga
Read moreAre Medical Stocks Lagging Cabaletta Bio (CABA) This Year?
10/09 09:40 am
Zacks Investment Research
Read moreThe Latest Analyst Ratings for Cabaletta Bio
10/04 11:00 am
Benzinga
Read moreQIAGEN (QGEN) Extends the AI-Powered QCI Interpret Software
10/02 09:14 am
Zacks Investment Research
Read moreWhat Makes Cabaletta Bio, Inc. (CABA) a Good Fit for 'Trend Investing'
09/25 08:50 am
Zacks Investment Research
Read moreCabaletta Bio to Participate in Upcoming Investor Conferences in September
09/19 08:00 am
GlobeNewswire Inc.
Read moreCabaletta Bio, Inc. (CABA) is on the Move, Here's Why the Trend Could be Sustainable
09/08 08:50 am
Zacks Investment Research
Read moreWhy America's Car-Mart Are Trading Lower By 12%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
09/05 01:34 pm
Benzinga
Read moreBenzinga's Top Ratings Upgrades, Downgrades For September 5, 2023
09/05 11:00 am
Benzinga
Read moreBrady, Airbnb, Insmed And Other Big Stocks Moving Higher On Tuesday
09/05 10:43 am
Benzinga
Read moreAnalyst Ratings for Cabaletta Bio
09/05 08:00 am
Benzinga
Read moreWall Street Analysts Believe Cabaletta Bio, Inc. (CABA) Could Rally 41.61%: Here's is How to Trade
08/31 09:55 am
Zacks Investment Research
Read moreRecent Price Trend in Cabaletta Bio, Inc. (CABA) is Your Friend, Here's Why
08/23 08:50 am
Zacks Investment Research
Read moreDoes Cabaletta Bio, Inc. (CABA) Have the Potential to Rally 27.85% as Wall Street Analysts Expect?
08/15 01:46 pm
Zacks Investment Research
Read moreHC Wainwright & Co. Maintains Buy Rating for Cabaletta Bio: Here's What You Need To Know
08/11 01:00 pm
Benzinga
Read moreCabaletta Bio Appoints Global Commercial Leader Shawn Tomasello to Board of Directors
07/24 08:00 am
GlobeNewswire Inc.
Read moreAnalyst Sees Positive Outlook For Cabaletta Bio: Sees Promise In CAR-T Therapy Approach
07/18 02:27 pm
Benzinga
Read moreBenzinga's Top Ratings Upgrades, Downgrades For July 18, 2023
07/18 11:00 am
Benzinga
Read moreLa-Z-Boy, FedEx And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
06/21 06:39 am
Benzinga
Read moreCabaletta Bio Announces Pricing of Public Offering of Common Stock
05/17 10:16 pm
GlobeNewswire Inc.
Read moreCabaletta Bio Announces Proposed Public Offering of Common Stock
05/17 04:01 pm
GlobeNewswire Inc.
Read more